| Units | Total | Attack | Remission | Acute MY subgroup | Acute ON subgroup | Acute BRAIN subgroup |
---|---|---|---|---|---|---|---|
Blood–CSF barrier function | |||||||
 QAlb > QAlb(lim) | Samples | 36/79 (45.6%) | 36/71 (50.7%) | 0/6 (0%) | 15/23 (65.2%) | 6/21 (28.6%) | 15/27 (55.6%) |
 QAlb, all LPs | – | 4 (1.8–15; 78) | 4.5 (1.8–15; 70) | 3.3 (2.6–3.7; 6) | 6 (1.8–11.5; 23) | 3.2 (1.9–11.6; 20) | 4.6 (1.9–15; 27) |
 QAlb, if positive | – | 6.9 (4.52–15.04; 35) | 6.9 (4.52–15.04; 35) | 0 (0–0; 0) | 8 (4.5–11.5; 15) | 5.1 (4.6–11.6; 5) | 6.7 (4.5–15; 15) |
 Alb CSF | mg/l | 186 (76.8–624; 78) | 198 (76.8–624; 70) | 131.5 (113–161; 6) | 237 (76.8–572; 23) | 143 (82–520; 19) | 198 (77–624; 28) |
 Alb serum | g/l | 43.35 (30.5–53.9; 78) | 43.4 (30.5–53.9; 70) | 42.6 (36–45.3; 6) | 43.4 (32–53.8; 25) | 44 (37.3–48.5; 19) | 42.2 (30.5–53.9; 26) |
 Albumin–cellular dissociation | Samples | 8/36 (22.2%) | 8/36 (22.2%) | 0/0 (0%) | 1/15 (6.7%) | 4/6 (66.7%) | 3/15 (20%) |
 Combined intrathecal IgG | |||||||
 synthesis and BCB disruption | Samples | 7/36 (19.4%) | 7/36 (19.4%) | 0/0 (0%) | 6/15 (40%) | 0/6 (0%) | 1/15 (6.7%) |
CSF total protein | |||||||
 CSF TP, all LPs | mg/dl | 30.95 (10–97.2; 98) | 32.2 (13.4–97.2; 87) | 22.1 (10–56.6; 9) | 42.1 (14–89; 28) | 25.6 (13.4–64; 23) | 32.6 (14.2–97.2; 36) |
 CSF TP, > 100 mg/dl | Samples | 0/98 (0%) | 0/87 (0%) | 0/9 (0%) | 0/28 (0%) | 0/23 (0%) | 0/0 (0%) |
 CSF TP, elevated (> 45 mg/dl) | Samples | 22/98 (22.4%) | 21/87 (24.1%) | 1/9 (11.1%) | 10/27 (37%) | 1/25 (4%) | 10/35 (28.6%) |
 CSF TP, if elevated (> 45 mg/dl) | mg/dl | 58.3 (46.3–97.2; 22) | 60 (46.3–97.2; 21) | 56.6 (56.6–56.6; 1) | 57 (46.3–89; 10) | 64 (64–64; 1) | 57 (49–97.2; 10) |
 CSF TP, elevated (age–adapteda) | Samples | 59/98 (60.2%) | 54/87 (62.1%) | 3/9 (33.3%) | 55/85 (64.7%) | 2/11 (18.2%) | 52/77 (67.5%) |
 CSF TP, if elevated (age-adapteda) | mg/dl | 41 (26.1–97.2; 59) | 42.6 (26.1–97.2; 54) | 40 (31.7–56.6; 3) | 42 (26.1–97.2; 55) | 38.7 (28.4–49; 2) | 42.6 (26.1–97.2; 52) |
CSF l-lactate | |||||||
 CSF l-lactate, elevated | samples | 22/72 (30.6%) | 20/66 (30.3%) | 2/6 (33.3%) | 10/22 (45.5%) | 4/21 (19%) | 6/23 (26.1%) |
 CSF l-lactate, all LPs | mmol/l | 1.6 (0.9–2.83; 70) | 1.6 (0.9–2.83; 64) | 1.7 (1–2.11; 6) | 1.74 (1–2.6; 22) | 1.5 (0.97–2.56; 19) | 1.57 (0.9–2.83 ;23) |
 CSF lactate, if elevated | mmol/l | 2 (1.8–2.83; 22) | 2 (1.8–2.83; 20) | 2.01 (1.9–2.11; 2) | 2.04 (1.38–2.6; 6) | 1.53 (1.53–1.53; 1) | 1.57 (1.1–2.83; 7) |
 CSF l-lactate, > 3 mmol/l | samples | 0/70 (0%) | 0/64 (0%) | 0/6 (0%) | 0/22 (0%) | 0/19 (0%) | 0/23 (0%) |